Similar articles

• Anti-IgE for asthma in inner-city children.

  Geraci C, Longo G. Geraci C, et al. N Engl J Med. 2011 Jun 30;364(26):2557; author reply 2557-8. doi: 10.1056/NEJMc1104264. N Engl J Med. 2011. PMID: 21714663 No abstract available.
• Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children.

  Busse WW, Morgan WJ, Gergen PJ, Mitchell HE, Gern JE, Liu AH, Gruchalla RS, Kattan M, Teach SJ, Pongracic JA, Chmiel JF, Steinbach SF, Calatroni A, Togias A, Thompson KM, Szefler SJ, Sorkness CA. Busse WW, et al. N Engl J Med. 2011 Mar 17;364(11):1005-15. doi: 10.1056/NEJMoa1009705. N Engl J Med. 2011. PMID: 21410369 Free PMC article. Clinical Trial.
• Monitoring Allergic Patients on Omalizumab with Free and Total Serum IgE Measurements.

  Hamilton RG. Hamilton RG. J Allergy Clin Immunol Pract. 2016 Mar-Apr;4(2):366-8. doi: 10.1016/j.jaip.2015.12.002. J Allergy Clin Immunol Pract. 2016. PMID: 26968963 No abstract available.
• A recombinant humanized anti-IgE monoclonal antibody (omalizumab) in the therapy of moderate-to-severe allergic asthma.

  D'Amato G, Piccolo A, Salzillo A, Noschese P, D'Amato M, Liccardi G. D'Amato G, et al. Recent Pat Inflamm Allergy Drug Discov. 2007 Nov;1(3):225-31. doi: 10.2174/187221307782418900. Recent Pat Inflamm Allergy Drug Discov. 2007. PMID: 19075985 Review.
• [Pneumology. Anti-IgE antibodies in the treatment of asthma].

  Leuenberger P, Sauty A, Rochat T. Leuenberger P, et al. Rev Med Suisse. 2007 Jan 10;3(93):56-9. Rev Med Suisse. 2007. PMID: 17354662 Review. French.